Coloplast A/S (CLPBY) Expected to Announce Earnings on Tuesday

by · The Cerbat Gem

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) will likely be announcing its earnings results before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.09 per share and revenue of $7.02 billion for the quarter. Coloplast A/S has set its FY 2025 guidance at EPS.

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. On average, analysts expect Coloplast A/S to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Coloplast A/S Stock Performance

Shares of OTCMKTS:CLPBY traded down $0.09 on Monday, hitting $10.55. 76,857 shares of the company were exchanged, compared to its average volume of 206,827. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.66 and a current ratio of 1.02. The company’s 50 day moving average price is $10.60 and its two-hundred day moving average price is $11.39. Coloplast A/S has a one year low of $9.67 and a one year high of $14.14.

Analyst Upgrades and Downgrades

Several research firms have commented on CLPBY. Sanford C. Bernstein raised Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Royal Bank of Canada upgraded Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research note on Monday, March 3rd.

Read Our Latest Report on Coloplast A/S

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

Further Reading